165 related articles for article (PubMed ID: 8082695)
1. Formoterol and salmeterol are both long acting compared to terbutaline in the isolated perfused and ventilated guinea-pig lung.
Jeppsson AB; Nilsson E; Waldeck B
Eur J Pharmacol; 1994 May; 257(1-2):137-43. PubMed ID: 8082695
[TBL] [Abstract][Full Text] [Related]
2. Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline.
Richter K; Janicki S; Jörres RA; Magnussen H
Eur Respir J; 2002 May; 19(5):865-71. PubMed ID: 12030726
[TBL] [Abstract][Full Text] [Related]
3. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
4. Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction.
Politiek MJ; Boorsma M; Aalbers R
Eur Respir J; 1999 May; 13(5):988-92. PubMed ID: 10414394
[TBL] [Abstract][Full Text] [Related]
5. Formoterol on airway smooth muscle and human lung mast cells: a comparison with salbutamol and salmeterol.
Nials AT; Ball DI; Butchers PR; Coleman RA; Humbles AA; Johnson M; Vardey CJ
Eur J Pharmacol; 1994 Jan; 251(2-3):127-35. PubMed ID: 8149969
[TBL] [Abstract][Full Text] [Related]
6. Studies on the interaction between formoterol and salmeterol in guinea-pig trachea in vitro.
Jeppsson AB; Källström BL; Waldeck B
Pharmacol Toxicol; 1992 Oct; 71(4):272-7. PubMed ID: 1360657
[TBL] [Abstract][Full Text] [Related]
7. Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.
Lindén A; Bergendal A; Ullman A; Skoogh BE; Löfdahl CG
Thorax; 1993 May; 48(5):547-53. PubMed ID: 8100652
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung.
Whelan CJ; Johnson M; Vardey CJ
Br J Pharmacol; 1993 Oct; 110(2):613-8. PubMed ID: 7902175
[TBL] [Abstract][Full Text] [Related]
9. Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms.
Cooper PR; Kurten RC; Zhang J; Nicholls DJ; Dainty IA; Panettieri RA
Br J Pharmacol; 2011 Jun; 163(3):521-32. PubMed ID: 21306583
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological similarities and differences between beta2-agonists.
Lötvall J
Respir Med; 2001 Aug; 95 Suppl B():S7-11. PubMed ID: 11534896
[TBL] [Abstract][Full Text] [Related]
11. Duration of action of inhaled vs. Intravenous beta(2)-adrenoceptor agonists in an anaesthetized guinea-pig model.
Mohammed SP; Taylor CV; Weyman-Jones CB; Mather ME; Vendy K; Dougall IG; Young A
Pulm Pharmacol Ther; 2000; 13(6):287-92. PubMed ID: 11061983
[TBL] [Abstract][Full Text] [Related]
12. Onset of action and duration of effect of formoterol and salmeterol compared to salbutamol in isolated guinea pig trachea with or without epithelium.
Ullman A; Bergendal A; Lindén A; Waldeck B; Skoogh BE; Löfdahl CG
Allergy; 1992 Aug; 47(4 Pt 2):384-7. PubMed ID: 1360770
[TBL] [Abstract][Full Text] [Related]
13. Formoterol and salmeterol in partially reversible chronic obstructive pulmonary disease: A crossover, placebo-controlled comparison of onset and duration of action.
Celik G; Kayacan O; Beder S; Durmaz G
Respiration; 1999; 66(5):434-9. PubMed ID: 10516540
[TBL] [Abstract][Full Text] [Related]
14. Different effects of salmeterol, formoterol and salbutamol on cholinergic responses in the ferret trachea.
Bergendal A; Lindén A; Lötvall J; Skoogh BE; Löfdahl CG
Br J Pharmacol; 1995 Apr; 114(7):1478-82. PubMed ID: 7606351
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
Grove A; Lipworth BJ
Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370
[TBL] [Abstract][Full Text] [Related]
16. Long acting inhaled beta-adrenoceptor agonists the comparative pharmacology of formoterol and salmeterol.
Anderson GP
Agents Actions Suppl; 1993; 43():253-69. PubMed ID: 8103622
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of indacaterol, a novel once daily inhaled 2 adrenoceptor agonist, on small airways in human and rat precision-cut lung slices.
Sturton RG; Trifilieff A; Nicholson AG; Barnes PJ
J Pharmacol Exp Ther; 2008 Jan; 324(1):270-5. PubMed ID: 17916760
[TBL] [Abstract][Full Text] [Related]
18. Bronchodilating properties of the VIP receptor agonist Ro 25-1553 compared to those of formoterol on the guinea-pig isolated trachea.
Källström BL; Waldeck B
Eur J Pharmacol; 2001 Nov; 430(2-3):335-40. PubMed ID: 11711052
[TBL] [Abstract][Full Text] [Related]
19. Functional and binding characteristics of long-acting beta 2-agonists in lung and heart.
Roux FJ; Grandordy B; Douglas JS
Am J Respir Crit Care Med; 1996 May; 153(5):1489-95. PubMed ID: 8630591
[TBL] [Abstract][Full Text] [Related]
20. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF
Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]